𝑪𝒍𝒐𝒔𝒊𝒏𝒈 𝒕𝒊𝒎𝒆… Atabix has completed the acquisition of Mozard and IenPM, enhancing its position in the market. Through the acquisition of Mozard and IenPM , Atabix acquires domain knowledge and innovative products, further cementing its role as a software provider and knowledge partner for (semi-)governmental organizations. TIC Advisory | Financial Due Diligence is proud to have contributed to this transaction by providing Buy-side Due Diligence. We express our gratitude to DELTA Equity Partners and Atabix for their collaboration and also extend our thanks to all other advisors involved in this transaction! For more detailed information, please see the press release: https://lnkd.in/eS3MZBFa
TIC Advisory | Financial Due Diligence’s Post
More Relevant Posts
-
RENEWALS can be a PAIN – especially when non-standard terms apply. While every deal has it’s own nuances, how you manage that pain is totally up to you. DatumNexus® will help you Verify, Validate and Identify the Risk involved in your renewals and more. www.datumnexus.co #mergersandacquisitions #dataintegrity
-
-
Unlocking Potential: A Deep Dive into the Indegene IPO and Market Sentiments... https://lnkd.in/e-Rgn76B #indegeneipo #indegeneiporeview #indegeneipodate #indegeneipopriceband #ipo #ipotoday #stockmarket #sharemarkettoday #indiansharemarket #indianstockmarket #markettrendzona market zona
-
In M&A, buyers are commonly classified under two types: strategic buyers and financial buyers. These differ based on various criteria including deal motivation, post-acquisition strategy, management involvement, and ownership stake. Check out the AleharX article to learn more about the differences between these two types of buyers. https://lnkd.in/gBzNwNS8 #mergersandacquisitions #buyside #AleharX
-
RENEWALS can be a PAIN – especially when non-standard terms apply. While every deal has it’s own nuances, how you manage that pain is totally up to you. DatumNexus® will help you Verify, Validate and Identify the Risk involved in your renewals and more. www.datumnexus.co #mergersandacquisitions #dataintegrity
-
-
LegaLogic Consulting Advises Infogen Labs "A Ciklum Company" Aanchal Lamba, Janhavi Jatar, Srishti Singh, Kunal Dodeja and Apurv Sardeshmukh represented Infogen with strategic guidance from Vivek Sadhale Read More: https://lnkd.in/gfi53JGu Annurag Batra Ashima Ohri BW Businessworld exchange4media #BWLegalWorld #Acquisition #LegalAdvice #LegalNews #EngineeringService #LawyersofLinkedin
LegaLogic Consulting Advises Infogen Labs
bwlegalworld.businessworld.in
-
CEO | Board Director | Cell and Gene Therapy |Rare Disease Patient Advocate |Global Network | Women's Leadership
An important market trend to watch! #SPACs might never fully go away if the ambitions of three new healthcare-focused shops have any sway. As initial public offerings are far and few between, and even reverse mergers have fallen by the wayside, blank-check companies might fill a gap in the public markets, or so their sponsors are betting. Voyager Acquisition filed for a $261 million IPO on Tuesday, Sim Acquisition’s $200 million plans appeared on Monday and Launch One Acquisition’s paperwork for a $200 million debuted last week. All three wrote in their S-1 documents that they hope to carry a company in the healthcare industry onto the public markets. Launch One wrote that it’s particularly interested in “life sciences, globally.” #IPO #capitalmarket #publicmarket #healthcare #lifescience #lifesciences #celltherapy #genetherapy #cellandgenetherapy #advancedtherapies #publicofferings #VoyagerAcquisition #SimAcquisition #LaunchOne #biotech #biotechnology #biotechnews
Three healthcare SPACs reveal their IPO plans
https://endpts.com
-
🚀 Great news for investors! Kronox Lab Sciences Limited IPO is live today, and GCL Broking's expert advice is to "Apply"! This is your chance to invest in a pioneering biotech company with immense growth potential. Seize this opportunity and be a part of their success story. Stay tuned with GCL Broking for more updates and professional guidance. 📈 📞𝘾𝙖𝙡𝙡 𝙪𝙨 𝙖𝙩 𝟬𝟭𝟰𝟭𝟲𝟲𝟮𝟱𝟱𝟬𝟬 or visit our website https://gclbroking.com #kronox #kronoxlabsciences #kronoxlabscienceslimited #KronoxIPO #InvestmentOpportunity #StockMarket #InvestmentAdvice #InvestmentAlert #InvestorAlert #StockMarketNews #IPO #IPOAlert #IPOInsights #iponews #ipoupdate #ShareMarket #Stocks #stockmarketindia #stockmarkettoday #stockmarketinvesting #sharemarkettoday #sharemarketnews #invest #investments #stockmarketsuccess #InvestSmart #investwisely #stocktrading #upcomingipo
-
Today Quanex revised the terms of its cash and shares offer for the British doors and windows company Tyman, adding a 15 pence special dividend to compensate for a decline in Quanex’s share price since the deal was announced. Based on Quanex’s latest closing price, the revised terms still represent a 4% reduction on the value when the offer was first announced on 22 April. However, as with Blackstone in its bid for Hipgnosis earlier this week, Quanex has declared that the offer is final and will not be increased. The data seems to show that this tactic is effective. Over the last five years, in non-hostile and non-competitive situations, there have been “no increase” statements in 25 UK public offers and only one of those deals has failed (Ramsay Health’s offer for Spire Healthcare in 2021). #manda #mergersandacquisitions #londonstockexchange #tyman
-
-
#Zoetis Announces $6 Billion Share Repurchase Program - https://lnkd.in/ePzrD48V has authorized a multi-year $6 billion share repurchase program, marking a significant step in its ongoing efforts to return value to shareholders. This initiative reflects the company's confidence in its financial strength and growth prospects. Financial Strategy and Shareholder Value #Zoetis announced its multi-year $6 billion share repurchase program, aiming to#$6 billion repurchase #analyst insights #financial strategy #growth initiatives #Kristin Peck #market reaction #Share Repurchase Program #shareholder value #strategic investments #Wetteny Joseph #Zoetis
-
